US Corporate Board Director Changes SEC Filings — June 30, 2026

30-06-2026

Nexscient, Inc. announced the resignation of COO Tarek Shoufani effective June 30, 2026, who will remain on the board as a non-employee director. The company also appointed Jaime Fanlo as an independent director effective July 1, 2026, and granted performance-based RSU awards of 250,000 shares each to Shoufani, Fanlo, and Eric Manlunas, with vesting tied to market capitalization thresholds over a 10-year period. No cash compensation is provided to non-employee directors.

• · Mr. Shoufani's resignation was not due to any disagreement with the company.
• · Jaime Fanlo holds a BA in Political Economy from the University of Asia and the Pacific and a Juris Doctor from Ateneo de Manila School of Law (2007).
• · Fanlo has over 18 years of cross-border experience in corporate governance, private equity, and commercial law.
• · Fanlo is a current stockholder of the company and serves as a director of subsidiaries Crestview BPO and Flipside AI.
• · The Board determined Fanlo qualifies as an independent director under Nasdaq and SEC standards; he has not been assigned to any board committee.
• · No cash retainer, meeting fee, or cash stipend is paid to non-employee directors; compensation is solely performance-based RSU awards plus expense reimbursement and indemnification.
• · RSU awards are granted as standalone inducement awards, not under any equity incentive plan.
• · Unvested RSUs are forfeited if performance thresholds are not met within 10 years; immediate forfeiture occurs upon termination for cause.
• · Accelerated vesting is provided in connection with a change of control.

30-06-2026

Rani Therapeutics appointed Nicholas M. Maestas as CFO effective June 29, 2026, replacing Svai Sanford. Maestas receives a $500,000 base salary, 75% target bonus, and a 2,000,000-share option grant under a new 2026 Equity Inducement Plan that reserves 5,500,000 shares. The company’s board approved the inducement plan on June 28, 2026, and stockholder approval is not required under Nasdaq Rule 5635(c)(4).

• · The Inducement Plan was approved by the Board on June 28, 2026, without stockholder approval, as permitted by Nasdaq Rule 5635(c)(4).
• · Maestas served as CFO and Head of Corporate Strategy at Tempest Therapeutics from Jan 2025 to Jun 2026, and previously as VP of Finance and Strategy from Jul 2021.
• · He holds a B.A. in Molecular and Cell Biology from UC Berkeley and an MBA from Wharton.

30-06-2026

Magnachip Semiconductor announced the appointment of Chae Lee as Chief Executive Officer, effective July 1, 2026, succeeding Camillo Martino who served as Interim CEO since August 2025. Martino will continue as Chairman of the Board. Lee brings over 30 years of semiconductor industry experience, most recently as CEO of Tagore Technology, and is expected to join the Board after his appointment.

• · Lee's appointment is effective July 1, 2026.
• · Martino served as Interim CEO since August 2025.
• · Lee previously served as CEO of Tagore Technology, a provider of GaN semiconductor solutions for RF and Power applications.
• · Lee also held senior leadership positions at Insyte Systems, NXP Semiconductors, and Maxim Integrated Products.
• · Magnachip has about 45 years of operating history and owns a substantial number of registered patents and pending applications.

30-06-2026

Palvella Therapeutics appointed Matthew Pauls as a Class I director on June 29, 2026, expanding the board from seven to eight members. Mr. Pauls brings extensive biopharmaceutical leadership experience, including serving as CEO of Savara, Inc. and previously leading Strongbridge Biopharma through its IPO and commercialization. He received an option to purchase 6,000 shares vesting over 36 months, with no immediate financial impact or related party transactions disclosed.

• · Mr. Pauls served as Lead Independent Director of Soleno Therapeutics from 2024 until its $2.9 billion acquisition by Neurocrine Biosciences in 2026.
• · Mr. Pauls holds a B.S., an M.B.A. from Central Michigan University, and a J.D. from Michigan State University College of Law.
• · The Board determined Mr. Pauls is independent under Nasdaq listing rules.
• · No arrangements or understandings exist between Mr. Pauls and any other person regarding his selection as a director.
• · Mr. Pauls does not have any family relationships with any of the Company’s directors or executive officers.

30-06-2026

The filing reports the departure of a director/officer and the appointment of a new director/officer, but no specific names, positions, or reasons are disclosed. No financial metrics, compensation details, or scheduled events are provided. The filing is informational with no material quantitative data to assess.

• · Filing date: June 30, 2026
• · AccNo: 0001903596-26-000268
• · Company: Graphene & Solar Technologies Ltd
• · Event type: Officer Change
• · Items reported: 5.02, 8.01, 9.01
• · No specific names, positions, or reasons for departure/appointment disclosed
• · No financial data, compensation, or forward-looking guidance provided

30-06-2026

First Financial Corp (THFF) entered into new employment agreements with three senior officers (CFO, CCO, CLO) effective July 1, 2026, with base salaries of $387,131 for McHargue, $317,228 for Panagouleas, and $319,307 for Franklin. The 24-month agreements include non-compete and change-in-control severance provisions (2x base salary plus bonus and benefits), but no financial results or performance metrics were disclosed.

• · Agreements effective July 1, 2026, with initial term of 24 months, renewable annually at compensation committee's discretion.
• · Non-compete radius: 75 miles (50 miles if terminated without cause or for good reason) from Terre Haute for McHargue & Panagouleas, from Bloomington for Franklin.
• · Severance for termination without cause (not within 12 months of change of control) equals base salary plus bonuses through the end of the current term plus cash reimbursements for benefits.
• · Change-in-control severance: 2.00 times (base salary + prior year bonuses + benefits cost for 2 years), subject to 280G excise tax cutback if advantageous.
• · Agreements include confidentiality and non-solicitation provisions.

30-06-2026

Sera Prognostics appointed Mark Capone, former CEO of Myriad Genetics, to its Board of Directors effective July 1, 2026. Capone brings over 40 years of diagnostics and life sciences leadership, including expertise in commercializing complex diagnostic products and navigating reimbursement environments, which the company expects will support adoption of its PreTRM test. The filing does not disclose any financial metrics or performance data, so no period-over-period comparisons are available.

• · Mark Capone served as CEO of Myriad Genetics, leading its transformation into a precision medicine organization and expanding its molecular diagnostics portfolio.
• · Capone held senior leadership roles at Myriad over 17 years, including President and COO.
• · Earlier in his career, Capone held leadership positions at Eli Lilly and other healthcare organizations.
• · The PreTRM Test is the only broadly validated, commercially available blood-based biomarker test for spontaneous preterm birth risk prediction in asymptomatic singleton pregnancies.
• · The U.S. earned a D+ grade for preterm birth for the fourth consecutive year (2025 March of Dimes Report Card).
• · Annual healthcare costs for prematurity in the U.S. were estimated at approximately $25 billion for 2016.

30-06-2026

Terex Corporation held its 2026 Annual Meeting on June 25, 2026, where stockholders elected 12 directors, approved executive compensation on an advisory basis, ratified KPMG as auditor, and approved the 2026 Omnibus Incentive Plan. All director nominees received strong support, though Sandie O'Connor and David Sachs each had over 2.2 million votes against. The Omnibus Plan was approved with 98,052,459 for and 2,406,094 against.

• · Proposal 1: All directors elected with votes for ranging from 98,169,635 to 100,358,485.
• · Proposal 2: Advisory vote on executive compensation passed with 98,623,406 for, 1,814,075 against.
• · Proposal 3: Omnibus Plan approved with 98,052,459 for, 2,406,094 against.
• · Proposal 4: Ratification of KPMG passed with 106,154,545 for, 90,566 against.
• · Broker non-votes were 5,795,483 for all director elections and proposals 2 and 3.

30-06-2026

Twenty One Capital, Inc. appointed Karl Olsoni as an independent director and to its Audit Committee, effective June 30, 2026. Under the independent director agreement, Olsoni will receive an annual cash retainer of $150,000 and an annual equity award of $150,000 in Class A stock, plus expense reimbursement. The filing does not disclose any financial results or performance metrics, so no positive or negative trends are reported.

• · Olsoni's term expires at the 2027 annual general meeting of shareholders.
• · The equity award vests in full upon grant.
• · Olsoni is prohibited from serving on more than two Board committees simultaneously.
• · The Company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

30-06-2026

Analysis unavailable

30-06-2026

Skillsoft Corp. held its 2026 Annual Meeting on June 25, 2026, where stockholders approved the Second Amendment to the 2020 Omnibus Incentive Plan, increasing authorized shares by 550,000 to 4,305,658. The meeting also saw the election of three Class II directors and advisory approval of executive compensation. However, the Second Amendment received only 81.6% of votes cast in favor, with 18.4% against, indicating notable dissent.

• · The Second Amendment was approved with 5,191,165 votes for, 1,170,074 against, and 4,082 abstentions, plus 1,093,722 broker non-votes.
• · Advisory vote on executive compensation: 5,491,157 for, 868,427 against, 5,737 abstentions.
• · Ratification of Ernst & Young LLP: 7,452,117 for, 1,554 against, 5,372 abstentions (no broker non-votes).
• · Election results: Michael S. Klein received 5,903,836 votes for and 461,485 withheld; Denis Nikolaev 6,316,961 for and 48,360 withheld; Arthur Gilliland 6,322,093 for and 43,228 withheld.

30-06-2026

ChronoScale Corporation (formerly EKSO BIONICS HOLDINGS, INC.) expanded its board from seven to eight members and appointed Andrew Cordell Schaap as a director, effective June 29, 2026. Mr. Schaap also joined the Audit Committee (replacing Douglas Miller) and the Related Party Transactions Committee. He received a restricted stock award of 200,000 shares vesting in two equal annual installments. The filing also details the final committee assignments for the board.

• · The company's subsidiary is party to a data center lease with a company where Mr. Schaap serves as CEO and board member; the lease was entered into in the ordinary course of business.
• · Board committees established: Audit, Compensation, Nominating and Governance, and Related Party Transaction.
• · Committee chairs: Richard Nottenburg (Compensation), Ella Benson (Nominating and Governance), William M. Clancy (Audit and Related Party Transactions).
• · The restricted stock award vests in two equal annual installments on the first two anniversaries of the grant date, subject to continued service.
• · The filing is made under the name ChronoScale Corporation, indicating a possible name change from EKSO BIONICS HOLDINGS, INC.

30-06-2026

Blue Owl Digital Infrastructure Trust announced the appointment of Jack Viellieu as Chief Operating Officer, effective June 30, 2026, following the resignation of Bradley Berkley. Mr. Berkley's departure was not due to any disagreement with the company. Mr. Viellieu is a Managing Director at Blue Owl and brings experience from IPI Partners, Madison Dearborn Partners, and Credit Suisse.

• · Jack Viellieu is a Managing Director at Blue Owl and a member of the Digital Infrastructure Investment Team.
• · Mr. Viellieu joined IPI Partners in July 2019 and previously worked as a Private Equity Associate at Madison Dearborn Partners.
• · He began his career as an investment banking analyst at Credit Suisse in the Retail & Consumer Products Investment Banking Group.
• · Mr. Viellieu holds an M.B.A. from the University of Chicago Booth School of Business and a B.A. in Economics, magna cum laude, from Middlebury College.
• · There are no family relationships between Mr. Viellieu and any director or executive officer, and no reportable transactions under Item 404(a).

30-06-2026

Lands' End appointed Charlie Cole as CEO and board member, effective July 13, 2026, succeeding Andrew McLean who will resign and transition to a non-officer role through September 11, 2026. Cole brings extensive digital commerce and AI experience from Thuma, XGen AI, Tribute Technology, FTD, TUMI, and Samsonite. The filing outlines substantial compensation for Cole (base salary $1.1M, target bonus 125%, signing bonus $550,000, $2.5M in equity inducement grants) and a separation package for McLean including severance of 2x base plus average bonus, pro-rata bonus, accelerated vesting of certain equity, and benefits. No financial performance metrics were disclosed.

• · Charlie Cole's previous roles include Interim Chief Digital Officer of Thuma (Feb 2026–Jun 2026), President of XGen AI (Feb 2025–Feb 2026, acquired by Zoovu), CEO of Tribute Technology (Mar 2023–Nov 2024), CEO of FTD (Mar 2020–Jan 2023), Chief Digital Officer of TUMI (Jan 2016–Mar 2020), and Global Chief eCommerce Officer of Samsonite (Jan 2017–Mar 2020).
• · Cole's sign-on equity vests in tranches of 25%, 25%, and 50% on first, second, and third anniversaries respectively, with accelerated vesting of the portion that would vest within 12 months upon certain terminations.
• · Cole's cash signing bonus of $550,000 is subject to repayment if he resigns without good reason or is terminated for cause before January 31, 2027.
• · Mr. McLean will remain a non-officer employee through September 11, 2026, and will receive severance of 2x base salary plus average prior two years' bonus paid over 24 months, continued health insurance for 24 months, and outplacement for 12 months.
• · Mr. McLean will also receive accelerated vesting of 25% of RSUs granted April 4, 2025, and accelerated vesting of his unvested performance-vesting cash award granted March 13, 2026.
• · The agreements include non-competition (12 months standard, 24 months upon certain terminations), non-solicitation (18 months), and non-disparagement/confidentiality (24 months) covenants for Cole.

30-06-2026

Portillo's Inc. (PTLO) extended the interim CFO agreement with Pamela Smith through December 31, 2026 or until a permanent CFO is appointed, and also designated her as Treasurer. The amendment does not change her compensation or other material terms, and no new related-party transactions were disclosed.

• · The amendment extends the term of Ms. Smith's service as Interim CFO through the earlier of December 31, 2026 or the appointment of a permanent CFO.
• · Ms. Smith was also designated as Treasurer effective June 29, 2026, with customary duties and authority.
• · No changes were made to Ms. Smith's compensation or other material terms of the original agreement.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were reported.

30-06-2026

Ardent Health, Inc. (ARDT) filed an 8-K on June 30, 2026, disclosing that former President and CEO Martin J. Bonick entered into a Separation Agreement on June 26, 2026, following his departure effective June 2, 2026. The agreement provides severance benefits consistent with a termination without cause, and includes 12-month non-competition and non-solicitation covenants. No financial terms of the severance were disclosed, and no successor CEO has been announced.

• · The Separation Agreement was entered into on June 26, 2026, effective as of June 2, 2026.
• · Vesting and forfeiture of Bonick's time-based RSUs, performance-based RSUs, and restricted stock will be governed by existing incentive award plan and award agreements.
• · No financial details of the severance benefits were disclosed in the filing.

30-06-2026

ChargePoint Holdings, Inc. amended its Severance and Change in Control Agreement with CEO Richard Wilmer, removing the previously scheduled termination date of December 31, 2026, so that the agreement now continues until his actual separation from the company. This change provides continuity in executive retention but does not introduce any new financial metrics or performance data.

• · The original CIC Agreement was dated November 15, 2023.
• · The amendment was entered into on June 29, 2026.
• · The amendment removes the December 31, 2026 expiration date of the CIC Agreement.

30-06-2026

Imunon, Inc. announced the retirement of interim CFO Jeffrey Church effective July 1, 2026, and the appointment of Josh Blacher as his successor under a consulting agreement with Danforth Health, Inc. Mr. Church will remain as a consultant for a $10,000 monthly retainer. The transition is described as amicable with no disagreements with management.

• · Josh Blacher, age 54, has been an employee of Danforth Health since September 2022 and Managing Partner of Columbus Circle Capital LLC since August 2019.
• · Mr. Blacher holds a BA in Economics from Yeshiva University and an MBA in Finance from Columbia Business School.
• · The consulting agreement with Mr. Church can be terminated upon 2 business days' notice.
• · Mr. Blacher has no family relationship with any director or executive officer of Imunon and no material interest in any reportable transaction.

30-06-2026

Sunbelt Rentals Holdings, Inc. announced the appointment of Cynthia T. Jamison as a non-executive director to its Board of Directors, effective August 1, 2026. Ms. Jamison brings extensive board and executive leadership experience, including current roles at Advance Auto Parts, Darden Restaurants (chair), and International Flavors & Fragrances. The appointment is part of the company's Sunbelt 4.0 strategy execution.

• · Ms. Jamison holds a B.A. in political science and economics from Duke University and an M.B.A. in finance from the University of Chicago.
• · She is a certified public accountant, an NACD Fellow, and recently completed a four-year term on the Financial Accounting Standards Advisory Council.
• · Sunbelt Rentals operates over 1,600 locations with a fleet of assets exceeding $19 billion.
• · The company has 26,000 employees.

30-06-2026

Clean Energy Technologies, Inc. (CETY) announced the appointment of Ruoxin (Skyler) Wang and Zhang Zhixiang to its Board of Directors, effective June 21, 2026. Ms. Wang brings extensive investment and wealth management experience from Merrill Lynch and JPMorgan Chase, and will qualify as an independent director under Nasdaq rules. Mr. Zhang has served as CEO of China Ruifeng New Energy Holdings since 2010 and previously held senior roles at major Chinese financial institutions.

• · Ms. Wang served as Financial Advisor at Merrill Lynch from October 2022 to March 2025 and as Private Financial Advisor at JPMorgan Chase from 2019 to October 2022.
• · Mr. Zhang previously served as a director of Lion Group Holding Ltd. from June 2020 through September 2025.
• · Ms. Wang has been President of Rock Skyline LLC since December 2025.

30-06-2026

Rush Enterprises, Inc. announced the dual listing of its common stock on the Nasdaq Texas exchange, effective July 1, 2026, while maintaining its primary listing on the Nasdaq Global Select Market. The move does not involve new share issuance or changes to governance or reporting obligations. The company operates the largest network of commercial vehicle dealerships in North America, with 55 locations and approximately 2,400 employees in Texas.

• · The dual listing will not affect investors’ ability to buy or sell the Company’s common stock on the Nasdaq Global Select Market.
• · The Company’s common stock will continue to trade under the ticker symbols “RUSHA” and “RUSHB.”
• · The dual listing does not involve the issuance of new shares or change the Company’s governance structure or reporting obligations.
• · The Company expects the listing and trading of its common stock on Nasdaq Texas to commence on July 1, 2026.
• · Rush Enterprises has more than 160 locations in 24 states and Ontario, Canada.

30-06-2026

Nu Ride Inc. elected Paul W. Burkett as a Class II director effective July 1, 2026, and appointed him to the Audit, Corporate Governance and Nominating, and Transaction Committees. Concurrently, Michael J. Wartell resigned from the Board effective June 30, 2026, with no disagreements cited. The changes reflect routine board refreshment and committee strengthening.

• · Mr. Burkett has served as CEO of Snoaspen Insurance Group since August 1995.
• · He holds a J.D. from Concord Law School (2007) and a B.A. in International Relations from the University of Minnesota.
• · Mr. Burkett is a veteran of the United States Air Force.
• · Mr. Wartell's resignation was effective June 30, 2026, with no disagreements reported.

30-06-2026

Papa Johns announced the departure of CFO Ravi Thanawala, who is leaving for another public company, and appointed Chris Collins as interim CFO effective immediately. While the company highlighted Collins' experience and ongoing transformation priorities, the sudden CFO departure introduces leadership uncertainty. The company also announced its Q2 2026 earnings release date of August 6, 2026.

• · Ravi Thanawala will remain in an advisory capacity until July 31, 2026.
• · Marc Richard has assumed responsibility for all North America operations previously overseen by Thanawala as President.
• · Chris Collins previously served as interim CFO from March 2023 to July 2023.
• · Q2 2026 earnings will be released before market open on August 6, 2026, with a conference call at 8:00 a.m. ET.
• · Papa Johns has more than 6,000 restaurants in approximately 50 countries.

30-06-2026

Primis Financial Corp. announced the appointment of Margaret M. Weichert to its Board of Directors, effective June 30, 2026. Ms. Weichert brings extensive experience in financial services, technology, and government transformation. As of March 31, 2026, the company reported $4.3 billion in total assets, $3.4 billion in total loans held for investment, and $3.4 billion in total deposits.

• · Ms. Weichert has a 30-year record in financial services, including roles at Accenture, Bank of America, First Data, and The Clearinghouse.
• · She holds 16 U.S. patents and has led businesses with hundreds of millions in revenue and payment volume in trillions of dollars.
• · She served as Senate-confirmed Deputy for Management in the Office of Management and Budget and leader of the Office of Personnel Management.
• · She currently serves as an Adjunct Professor at Georgetown University and on the Advisory Board of the Smithsonian Libraries and Archives.

30-06-2026

Perrigo Company plc appointed Salman Amin and Omer Gajial as independent directors effective June 30, 2026. Both bring deep experience in consumer products, retail, and digital transformation, which the Board expects to support the company's strategic priorities. No financial metrics or performance data were disclosed in this filing.

• · Salman Amin most recently served as CEO of pladis Global, leading a multi-year transformation with sustained revenue growth and improved profitability.
• · Omer Gajial currently serves as CEO of GoTo Foods, a franchisor and operator of more than 7,000 restaurant and retail locations globally.
• · Prior to GoTo Foods, Gajial was EVP and Chief Merchandising & Digital Officer at Albertsons Companies.
• · Amin previously held senior leadership roles at PepsiCo and Procter & Gamble, and served as COO of the Global Commercial Division at SC Johnson.

30-06-2026

REalloys Inc. (BLBX) announced the resignation of CFO Robert Winspear effective June 24, 2026, with a severance package including $200,000 cash and 20,000 restricted shares. The company appointed Craig Cunningham as CFO via a consulting agreement with Provenance Advisors, with a base fee of $55,000/month ($660,000 annualized) and a target bonus of 100% of base. Additionally, director Joseph Sawyer resigned effective June 29, 2026, and the board does not plan to fill the vacancy. The changes are not due to any disagreements with the company.

• · Outgoing CFO Robert Winspear's resignation was not due to any disagreement with the company.
• · New CFO Craig Cunningham, age 43, previously served as CFO of Li-Cycle Holdings Corp. (March 2024 to April 2025) and Electra Battery Materials Corporation (June 2022 to July 2023).
• · Craig Cunningham will provide CFO services through Provenance Advisors as an independent contractor.
• · The consulting agreement automatically renews for successive 12-month terms unless either party gives 90 days' notice.
• · New CFO is eligible for annual equity refresh awards in subsequent years.
• · Director Joseph Sawyer resigned effective June 29, 2026, and the board does not intend to fill the vacancy.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

30-06-2026

R. Jason Richey resigned from the Board of Allurion Technologies and as Audit Committee chair on June 24, 2026, effective immediately. The resignation was not due to any disagreement with management or the Board. The Board is evaluating a replacement for the Audit Committee chair role.

• · Mr. Richey was a Class II director and chair of the Audit Committee.
• · Resignation effective June 24, 2026.
• · No disagreement with management or Board cited.

30-06-2026

Cloudflare, Inc. held its 2026 Annual Meeting of Stockholders on June 30, 2026, where shareholders approved all proposals, including the election of Class I directors, ratification of KPMG as auditor, advisory approval of executive compensation, and amendments to the certificate of incorporation to establish Class C common stock and increase authorized shares. The meeting also approved amendments to the 2019 Equity Incentive Plan and Employee Stock Purchase Plan. However, several proposals received significant opposition, with over 200 million votes against the Class C stock creation and share increases, indicating notable shareholder dissent.

• · Michelle Zatlyn received 568,227,358 votes for and 17,406,448 withheld; Scott Sandell received 529,020,167 for and 56,613,639 withheld; Karim Lakhani received 466,502,593 for and 119,131,213 withheld.
• · Proposal 4A (Class C stock creation) passed with 382,323,567 for and 200,557,125 against.
• · Proposal 4B (increase Class A authorized shares to 4.5B) passed with 388,797,473 for and 194,113,160 against.
• · Proposal 4C (increase preferred stock authorized shares to 450M) passed with 386,747,387 for and 196,165,702 against.
• · Proposal 4D (Class C Split) passed with 382,365,089 for and 200,521,452 against.
• · Proposal 4E (equal treatment of stock classes) passed with 388,499,421 for and 194,390,489 against.
• · Proposal 4F (independent director approval for large acquisitions) passed with 389,151,530 for and 193,726,819 against.
• · Proposal Five (Equity Incentive Plan amendment) passed with 363,236,265 for and 212,379,054 against.
• · Proposal Six (ESPP amendment) passed with 419,342,453 for and 166,193,708 against.
• · Proposal Seven (adjournment) was deemed unnecessary and not submitted due to sufficient votes.

30-06-2026

Jupiter Neurosciences appointed Dr. Tomas J. Philipson to its Board of Directors effective June 26, 2026, with simultaneous appointments to the Audit and Compensation Committees. Dr. Philipson, a health economist with senior government experience including as Acting Chairman of the White House Council of Economic Advisers, will receive equity compensation (both a sign-on option and an in-lieu-of-cash option) totaling 536,428 shares with quarterly vesting over 36 months. This appointment broadens the board's expertise but does not involve any disclosure-required transactions under Item 404(a).

• · Dr. Philipson will serve until the next annual meeting of stockholders.
• · Sign-on option exercise price equals fair market value on June 29, 2026 (Grant Date).
• · In-lieu-of-cash option covers compensation otherwise payable as annual cash retainer and committee fees.
• · No arrangements or understandings exist with other persons regarding selection as director.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K.

30-06-2026

ArrowMark Financial Corp. (BANX) announced the appointment of Katie Jones as CFO, effective immediately, replacing Pat Farrell who retired. Additionally, President Dana Staggs will depart effective August 2, 2026. The company expressed gratitude for both executives' service and noted that responsibilities will be assumed by existing team members.

• · Katie Jones has been with ArrowMark since 2019 when ArrowMark Partners assumed management of the Fund.
• · Dana Staggs' responsibilities will be assumed by multiple members of the investment team.
• · Pat Farrell's CFO responsibilities will be transitioned to Katie Jones.

30-06-2026

Rocket Pharmaceuticals announced the resignation of John Militello as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026, to pursue other opportunities. Joseph Manhede, currently Associate Vice President, Corporate Controller, will succeed him as Principal Accounting Officer effective July 8, 2026. No new compensatory arrangements or conflicts of interest were disclosed.

• · Joseph Manhede, age 48, has been with Rocket since April 2026 as Associate Vice President, Corporate Controller.
• · Mr. Manhede is a Certified Public Accountant (CPA) and holds an MBA from Holy Family University.
• · No family relationships or reportable transactions exist between Mr. Manhede and other directors or executive officers.

30-06-2026

Z Squared Inc. (Nasdaq: ZSQR) appointed Jeffrey Harris as Chief Technology Officer on June 30, 2026. Harris is the founder and CTO of Paradox Data LLC, a company Z Squared has a binding letter of intent to acquire a majority interest in. The appointment brings expertise in immersion cooling and high-density AI infrastructure, but the company has limited operating history in AI infrastructure and currently generates no revenue from that segment.

• · Z Squared listed on the Nasdaq Global Market in April 2026.
• · The company's current revenue is dependent on Dogecoin and Litecoin mining, not AI infrastructure.
• · The company has a limited operating history in AI infrastructure, data center development, and power generation, none of which currently generates revenue.
• · The company faces risks related to digital asset price volatility and the ability to continue as a going concern.

30-06-2026

Vivani Medical received regulatory approval from an Australian ethics committee (Bellberry) to initiate SLIM-1, a Phase 1 clinical trial of NPM-139, a semaglutide implant for obesity/weight management. The trial is expected to start in mid-2026 and will compare a low-dose NPM-139 implant against Wegovy (0.25 mg/week) over four weeks in 20 obese or overweight subjects (n=10 per group). The Company also plans a follow-up dose-ranging trial (SLIM-2) pending successful SLIM-1 results.

• · The trial is open-label, randomized, and active comparator-controlled.
• · Primary endpoints are safety, tolerability, and pharmacokinetics; weight loss is a secondary measure.
• · The trial builds on a prior Phase 1 study of NPM-119 (exenatide implant) conducted in Australia in 2025.
• · The Company’s NanoPortal platform is designed to deliver drugs steadily over extended periods, potentially improving medication adherence (noting approximately 50% of patients do not take daily pills as prescribed).
• · No financial or cash runway data was disclosed in this filing.

30-06-2026

Innventure, Inc. announced the appointment of Dr. Bill Grieco as its next CEO, effective October 1, 2026, succeeding Bill Haskell who is retiring after 45+ years, including six as CEO. The transition includes a three-month handover period and a planned first 100 days plan for milestone execution. No financial metrics or performance data were disclosed in this filing.

• · Dr. Grieco currently serves as founding CEO of Refinity and board member of Refinity and Accelsius.
• · From 2022 to 2024, Dr. Grieco served as Innventure's Chief Technology Officer.
• · Dr. Grieco earned a PhD and master's from MIT and a bachelor's from Georgia Tech, all in Chemical Engineering.
• · Dr. Grieco will join Innventure's executive committee and fill the vacancy on the Board created by Haskell's retirement.
• · Refinity and Innventure are working with an executive search firm to identify a successor CEO for Refinity.
• · Dr. Grieco will remain as Refinity CEO until October 1, 2026.

30-06-2026

Kennametal Inc. announced the appointment of Amanda Cole as Vice President and Chief Human Resources Officer, effective July 21, 2026, succeeding Judith Bacchus who will retire on or about October 1, 2026 after more than 20 years at the company. Cole brings over 20 years of HR leadership experience, most recently at Wesco International. The company generated $2 billion in revenues in fiscal 2025 and employs approximately 8,100 people.

• · Cole will oversee HR, corporate communications, and EHSQ activities.
• · Cole has a B.S. in industrial engineering from Penn State and an MBA from University of Baltimore.
• · Bacchus joined Kennametal in 2006 and led HR, communications, and EHSQ.

30-06-2026

PPL Corp announced the appointment of Kenneth M. Hartwick, former CEO of Ontario Power Generation, to its Board of Directors effective July 1, 2026. The board will consist of 10 directors, with Hartwick serving on the People and Compensation Committee and Finance Committee. No financial metrics or performance data were disclosed in this filing.

• · Effective date of Hartwick's appointment: July 1, 2026.
• · Hartwick served as president and CEO of Ontario Power Generation from 2019 to 2025.
• · He previously served as CFO of Ontario Power Generation and held leadership roles at Wellspring Financial Corporation, Just Energy Group, and Hydro One.
• · Hartwick began his career at Ernst & Young, becoming a partner advising energy and utilities clients.
• · He currently chairs the board of MYR Group Inc. and serves on the boards of Denison Mines Corp., Independent Electricity System Operator of Ontario, and Investment Management Corporation of Ontario.
• · PPL serves more than 3.6 million customers in the U.S.

30-06-2026

Consumers Bancorp Inc. announced the departure of Scott E. Dodds, Executive Vice President, Senior Loan Officer and Named Executive Officer, effective June 26, 2026, due to a disability. Mr. Dodds joined the company in November 2013 and his departure is not due to any disagreement with the board or management. He will receive disability benefits under the Salary Continuation Plan, a lump sum cash payment of $34,320, an advanced payout of paid time off of $10,730, and accelerated vesting of stock awards with a grant date fair value of $24,434.

• · Mr. Dodds served as Executive Vice President, Senior Loan Officer and Named Executive Officer since joining the company in November 2013.
• · His departure is due to a disability and not due to any disagreement with the Board of Directors or management.
• · No new material compensatory arrangements were entered into in connection with his departure.

30-06-2026

Autoliv announced that Kevin Fox is resigning as President of Autoliv Americas for personal reasons, remaining in his role through August 31, 2026, and then serving as senior advisor to the CEO through February 28, 2027. EVP Anthony Nellis will serve as acting President from September 1, 2026, until a successor is appointed. The company has launched a recruitment process for a permanent replacement.

• · Kevin Fox has been with Autoliv for 30 years (since 1996) and served as President of Autoliv Americas since June 2020, including 6 years on the Executive Management Team.
• · Anthony Nellis, currently EVP Legal Affairs, General Counsel and Secretary, will serve as acting President after August 31, 2026 with his primary office at Autoliv Americas headquarters.
• · The recruitment process for a permanent successor President is launching immediately.
• · Autoliv’s 2025 sales were $10.8 billion, with approximately 40,000 lives saved and 600,000 injuries reduced by its products.

30-06-2026

MSC Income Fund, Inc. (NYSE: MSIF) announced a CEO succession plan: Nicholas T. Meserve, currently a Managing Director and head of the private credit investment team, will become CEO in Q4 2026, while current CEO Dwayne L. Hyzak will remain as Executive Chairman. The transition is part of the board's long-term succession planning. No financial metrics or performance data were disclosed in this filing.

• · Mr. Meserve has been with Main Street's investment team since 2012 and a Managing Director of MSC Income since 2020.
• · Mr. Meserve previously served on MSC Income's Board from 2016 to 2020.
• · The Fund went public in 2025.
• · The Fund's private loan portfolio companies generally have annual revenues between $25 million and $500 million; lower middle market portfolio companies generally have annual revenues between $10 million and $150 million.

30-06-2026

American Shared Hospital Services held its Annual Meeting on June 24, 2026, where all four director nominees were elected and shareholders approved the Amended Incentive Compensation Plan, the advisory vote on executive compensation, and the ratification of Baker Tilly US, LLP as auditor. The proposals saw strong support, with the auditor ratification receiving 4,274,726 'for' votes, though proposals two and three had notable 'against' votes totaling 455,680 and 466,750 respectively.

• · Election of directors: Daniel G. Kelly, Jr. received 2,372,253 for and 420,123 withheld; Kathleen Miles 2,568,080 for and 224,296 withheld; Raymond C. Stachowiak 2,568,376 for and 224,000 withheld; Vicki L. Wilson 2,576,460 for and 215,916 withheld.
• · Proposal Two (Advisory vote on executive compensation): 455,680 votes against and 13,630 abstentions.
• · Proposal Three (Incentive Plan approval): 466,750 votes against and 10,073 abstentions.
• · Proposal Four (Ratification of Baker Tilly US, LLP): 197,844 votes against and 18,120 abstentions.
• · All proposals received at least a majority of votes cast and a majority of the quorum voting power.

30-06-2026

Exicure, Inc. announced the resignation of director Ham Jung Kyu effective June 30, 2026, and increased the board size from five to six directors. Go Jin Young and Han Eui Seok were appointed as Class III directors, with Han serving as independent and chair of the newly formed Compensation Committee. The changes appear routine and not driven by any disagreement with company operations.

• · Han Eui Seok, age 52, has been CEO of Sui Generis Co., Ltd. since 2018 and previously served as CEO of Archangel Investment Co., Ltd.
• · Go Jin Young, age 50, serves as CEO of Ghana Enterprise and as an Adjunct Professor at Honam University, and previously held vice chairman roles in committees of the Democratic Party of Korea.
• · Neither Go nor Han has any material interest in transactions required to be disclosed under Item 404(a) of Regulation S-K.
• · No family relationships exist between the new directors and any existing director or executive officer.

30-06-2026

Xeris Biopharma appointed CEO John Shannon as Chair of the Board, succeeding Marla Persky, who will remain as Lead Independent Director effective July 1, 2026. The board also expanded to eight members with the appointment of Dr. Nerissa Kreher, an experienced biotech executive, effective the same date. No financial metrics were reported in the filing, and the changes reflect governance and leadership transitions without quantitative performance data.

• · Dr. Nerissa Kreher is Chief Medical Officer of Alltrna and has over two decades of biotech experience.
• · Xeris has three marketed products: Recorlev (Cushing's syndrome), Gvoke (severe hypoglycemia), and Keveyis (primary periodic paralysis).
• · Pipeline includes XP-8121, a phase 3-ready once-weekly subcutaneous injection for hypothyroidism, and early-stage programs using XeriSol and XeriJect platforms.

30-06-2026

Universal Electronics Inc. (UEIC) announced that board member Sue Ann R. Hamilton resigned effective June 30, 2026, with no disputes or disagreements with management or the board. The departure reduces board size and committee composition, but the company did not disclose a replacement or any impact on operations.

• · Resignation effective June 30, 2026, one day after notification on June 29, 2026.
• · Ms. Hamilton served on board committees, which are now affected by her departure.
• · No replacement or search process mentioned in the filing.

30-06-2026

Workhorse Group Inc. held its 2026 annual meeting on June 29, 2026, where stockholders elected all seven director nominees, approved the say-on-pay proposal, ratified the appointment of Carr Riggs & Ingram as auditors, and approved an amended long-term incentive plan that adds 1,089,340 shares to the equity pool. The meeting had a quorum of 74.38% of outstanding shares. While all proposals passed, the incentive plan received the lowest support (6,849,267 for, 186,217 against) and the auditor ratification had the highest support (8,061,795 for, 86,613 against).

• · The incentive plan proposal received 6,849,267 votes for, 186,217 against, and 18,021 abstentions, with 1,121,390 broker non-votes.
• · The auditor ratification proposal had no broker non-votes and passed with 8,061,795 for, 86,613 against, and 26,487 abstentions.
• · The say-on-pay proposal received 6,938,904 for, 93,299 against, and 21,302 abstentions.
• · All director nominees received between 6,962,885 and 6,975,733 votes for, with the lowest support for Raymond J. Chess (6,962,885 for, 79,660 against).